| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 371 |
| 1 | METFORMIN ER 500 MG | 371 |
| 2 | METFORMIN ER 750 MG | 371 |
| 3 | INSULIN GLARGINE | 303 |
| 4 | INSULIN GLARGINE-YFGN | 147 |
| 5 | METFORMIN HYDROCHLORIDE | 103 |
| 6 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 102 |
| 7 | METFORMIN HYDROCHLORIDE TABLET | 102 |
| 8 | METFORMIN HYDROCHLORIDE TABLETS | 102 |
| 9 | FUROSEMIDE | 91 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 15 | 0.0090 |
| 1 | INSULIN GLARGINE-YFGN | 147 | 0.0066 |
| 2 | INSULIN ASPART INJECTION | 16 | 0.0059 |
| 3 | INSULIN GLULISINE | 43 | 0.0042 |
| 4 | ACARBOSE | 15 | 0.0038 |
| 5 | NICARDIPINE HYDROCHLORIDE | 8 | 0.0036 |
| 6 | SITAGLIPTIN PHOSPHATE | 8 | 0.0029 |
| 7 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 10 | 0.0029 |
| 8 | INSULIN DEGLUDEC | 51 | 0.0021 |
| 9 | PATISIRAN | 6 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 438 |
| 1 | Corticosteroid [EPC] | 180 |
| 2 | GLP-1 Receptor Agonist [EPC] | 150 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 148 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 107 |
| 5 | Loop Diuretic [EPC] | 92 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 90 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 86 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 82 |
| 9 | Sulfonylurea [EPC] | 82 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 15 | 0.0031 |
| 1 | Leptin Analog [EPC] | 3 | 0.0024 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 12 | 0.0021 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 82 | 0.0014 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 148 | 0.0014 |
| 6 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 43 | 0.0013 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 10 | 0.0011 |
| 8 | Insulin Analog [EPC] | 438 | 0.0010 |
| 9 | Glinide [EPC] | 8 | 0.0009 |